Project Description

For an investor presentation by the California biotech company, Neurocrine, we needed to depict vesicles traveling down the interior of a nerve cell, with Neurocrine’s compound attaching to receptors on the vesicle’s surface, trapping the dopamine inside. The drug was created to reverse the effects of psychoactive drugs in patients suffering from Tardive Dyskinesia.